A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats

Hark Soo Park, Sung Sup Shin, Eun Ho Meang, Jeong Sup Hong, Jong Il Park, Su Hyon Kim, Sang Bum Koh, Seung Young Lee, Dong Hyouk Jang, Jong Yun Lee, Yle Shik Sun, Jin Seok Kang, Yu Ri Kim, Meyoung-Kon Kim, Jayoung Jeong, Jong Kwon Lee, Woo Chan Son, Jae Hak Park

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: The widespread use of nanoparticles (NPs) in industrial and biomedical applications has prompted growing concern regarding their potential toxicity and impact on human health. This study therefore investigated the subchronic, systemic oral toxicity and no-observed-adverse-effect level (NOAEL) of 20 nm, negatively charged zinc oxide (ZnOSM20(−)) NPs in Sprague Dawley rats for 90 days. Methods: The high-dose NP level was set at 500 mg/kg of bodyweight, and the mid- and low-dose levels were set at 250 and 125 mg/kg, respectively. The rats were observed during a 14-day recovery period after the last NP administration for the persistence or reduction of any adverse effects. Toxicokinetic and distribution studies were also conducted to determine the systemic distribution of the NPs. Results: No rats died during the test period. However, ZnOSM20(−) NPs (500 mg/kg) induced changes in the levels of anemia-related factors, prompted acinar cell apoptosis and ductular hyperplasia, stimulated periductular lymphoid cell infiltration and excessive salivation, and increased the numbers of regenerative acinar cells in the pancreas. In addition, stomach lesions were seen at 125, 250, and 500 mg/kg, and retinal atrophy was observed at 250 and 500 mg/kg. The Zn concentration was dose-dependently increased in the liver, kidney, intestines, and plasma, but not in other organs investigated. Conclusion: A ZnOSM20(−) NP NOAEL could not be established from the current results, but the lowest-observed-adverse-effect level was 125 mg/kg. Furthermore, the NPs were associated with a number of undesirable systemic actions. Thus, their use in humans must be approached with caution.

Original languageEnglish
Pages (from-to)79-92
Number of pages14
JournalInternational Journal of Nanomedicine
Volume9
DOIs
Publication statusPublished - 2014 Dec 15

Fingerprint

Zinc Oxide
Zinc oxide
Nanoparticles
Sprague Dawley Rats
Toxicity
Rats
No-Observed-Adverse-Effect Level
Acinar Cells
Salivation
Cell death
Infiltration
Liver
Atrophy
Intestines
Hyperplasia
Anemia
Pancreas
Stomach
Health
Lymphocytes

Keywords

  • Negative charge
  • Oral toxicity study
  • Rat
  • ZnO

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Drug Discovery
  • Organic Chemistry

Cite this

A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats. / Park, Hark Soo; Shin, Sung Sup; Meang, Eun Ho; Hong, Jeong Sup; Park, Jong Il; Kim, Su Hyon; Koh, Sang Bum; Lee, Seung Young; Jang, Dong Hyouk; Lee, Jong Yun; Sun, Yle Shik; Kang, Jin Seok; Kim, Yu Ri; Kim, Meyoung-Kon; Jeong, Jayoung; Lee, Jong Kwon; Son, Woo Chan; Park, Jae Hak.

In: International Journal of Nanomedicine, Vol. 9, 15.12.2014, p. 79-92.

Research output: Contribution to journalArticle

Park, HS, Shin, SS, Meang, EH, Hong, JS, Park, JI, Kim, SH, Koh, SB, Lee, SY, Jang, DH, Lee, JY, Sun, YS, Kang, JS, Kim, YR, Kim, M-K, Jeong, J, Lee, JK, Son, WC & Park, JH 2014, 'A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats', International Journal of Nanomedicine, vol. 9, pp. 79-92. https://doi.org/10.2147/IJN.S57926
Park, Hark Soo ; Shin, Sung Sup ; Meang, Eun Ho ; Hong, Jeong Sup ; Park, Jong Il ; Kim, Su Hyon ; Koh, Sang Bum ; Lee, Seung Young ; Jang, Dong Hyouk ; Lee, Jong Yun ; Sun, Yle Shik ; Kang, Jin Seok ; Kim, Yu Ri ; Kim, Meyoung-Kon ; Jeong, Jayoung ; Lee, Jong Kwon ; Son, Woo Chan ; Park, Jae Hak. / A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats. In: International Journal of Nanomedicine. 2014 ; Vol. 9. pp. 79-92.
@article{73318b691f6d48cab7436cea8069f102,
title = "A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats",
abstract = "Purpose: The widespread use of nanoparticles (NPs) in industrial and biomedical applications has prompted growing concern regarding their potential toxicity and impact on human health. This study therefore investigated the subchronic, systemic oral toxicity and no-observed-adverse-effect level (NOAEL) of 20 nm, negatively charged zinc oxide (ZnOSM20(−)) NPs in Sprague Dawley rats for 90 days. Methods: The high-dose NP level was set at 500 mg/kg of bodyweight, and the mid- and low-dose levels were set at 250 and 125 mg/kg, respectively. The rats were observed during a 14-day recovery period after the last NP administration for the persistence or reduction of any adverse effects. Toxicokinetic and distribution studies were also conducted to determine the systemic distribution of the NPs. Results: No rats died during the test period. However, ZnOSM20(−) NPs (500 mg/kg) induced changes in the levels of anemia-related factors, prompted acinar cell apoptosis and ductular hyperplasia, stimulated periductular lymphoid cell infiltration and excessive salivation, and increased the numbers of regenerative acinar cells in the pancreas. In addition, stomach lesions were seen at 125, 250, and 500 mg/kg, and retinal atrophy was observed at 250 and 500 mg/kg. The Zn concentration was dose-dependently increased in the liver, kidney, intestines, and plasma, but not in other organs investigated. Conclusion: A ZnOSM20(−) NP NOAEL could not be established from the current results, but the lowest-observed-adverse-effect level was 125 mg/kg. Furthermore, the NPs were associated with a number of undesirable systemic actions. Thus, their use in humans must be approached with caution.",
keywords = "Negative charge, Oral toxicity study, Rat, ZnO",
author = "Park, {Hark Soo} and Shin, {Sung Sup} and Meang, {Eun Ho} and Hong, {Jeong Sup} and Park, {Jong Il} and Kim, {Su Hyon} and Koh, {Sang Bum} and Lee, {Seung Young} and Jang, {Dong Hyouk} and Lee, {Jong Yun} and Sun, {Yle Shik} and Kang, {Jin Seok} and Kim, {Yu Ri} and Meyoung-Kon Kim and Jayoung Jeong and Lee, {Jong Kwon} and Son, {Woo Chan} and Park, {Jae Hak}",
year = "2014",
month = "12",
day = "15",
doi = "10.2147/IJN.S57926",
language = "English",
volume = "9",
pages = "79--92",
journal = "International Journal of Nanomedicine",
issn = "1176-9114",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - A 90-day study of subchronic oral toxicity of 20 nm, negatively charged zinc oxide nanoparticles in Sprague Dawley rats

AU - Park, Hark Soo

AU - Shin, Sung Sup

AU - Meang, Eun Ho

AU - Hong, Jeong Sup

AU - Park, Jong Il

AU - Kim, Su Hyon

AU - Koh, Sang Bum

AU - Lee, Seung Young

AU - Jang, Dong Hyouk

AU - Lee, Jong Yun

AU - Sun, Yle Shik

AU - Kang, Jin Seok

AU - Kim, Yu Ri

AU - Kim, Meyoung-Kon

AU - Jeong, Jayoung

AU - Lee, Jong Kwon

AU - Son, Woo Chan

AU - Park, Jae Hak

PY - 2014/12/15

Y1 - 2014/12/15

N2 - Purpose: The widespread use of nanoparticles (NPs) in industrial and biomedical applications has prompted growing concern regarding their potential toxicity and impact on human health. This study therefore investigated the subchronic, systemic oral toxicity and no-observed-adverse-effect level (NOAEL) of 20 nm, negatively charged zinc oxide (ZnOSM20(−)) NPs in Sprague Dawley rats for 90 days. Methods: The high-dose NP level was set at 500 mg/kg of bodyweight, and the mid- and low-dose levels were set at 250 and 125 mg/kg, respectively. The rats were observed during a 14-day recovery period after the last NP administration for the persistence or reduction of any adverse effects. Toxicokinetic and distribution studies were also conducted to determine the systemic distribution of the NPs. Results: No rats died during the test period. However, ZnOSM20(−) NPs (500 mg/kg) induced changes in the levels of anemia-related factors, prompted acinar cell apoptosis and ductular hyperplasia, stimulated periductular lymphoid cell infiltration and excessive salivation, and increased the numbers of regenerative acinar cells in the pancreas. In addition, stomach lesions were seen at 125, 250, and 500 mg/kg, and retinal atrophy was observed at 250 and 500 mg/kg. The Zn concentration was dose-dependently increased in the liver, kidney, intestines, and plasma, but not in other organs investigated. Conclusion: A ZnOSM20(−) NP NOAEL could not be established from the current results, but the lowest-observed-adverse-effect level was 125 mg/kg. Furthermore, the NPs were associated with a number of undesirable systemic actions. Thus, their use in humans must be approached with caution.

AB - Purpose: The widespread use of nanoparticles (NPs) in industrial and biomedical applications has prompted growing concern regarding their potential toxicity and impact on human health. This study therefore investigated the subchronic, systemic oral toxicity and no-observed-adverse-effect level (NOAEL) of 20 nm, negatively charged zinc oxide (ZnOSM20(−)) NPs in Sprague Dawley rats for 90 days. Methods: The high-dose NP level was set at 500 mg/kg of bodyweight, and the mid- and low-dose levels were set at 250 and 125 mg/kg, respectively. The rats were observed during a 14-day recovery period after the last NP administration for the persistence or reduction of any adverse effects. Toxicokinetic and distribution studies were also conducted to determine the systemic distribution of the NPs. Results: No rats died during the test period. However, ZnOSM20(−) NPs (500 mg/kg) induced changes in the levels of anemia-related factors, prompted acinar cell apoptosis and ductular hyperplasia, stimulated periductular lymphoid cell infiltration and excessive salivation, and increased the numbers of regenerative acinar cells in the pancreas. In addition, stomach lesions were seen at 125, 250, and 500 mg/kg, and retinal atrophy was observed at 250 and 500 mg/kg. The Zn concentration was dose-dependently increased in the liver, kidney, intestines, and plasma, but not in other organs investigated. Conclusion: A ZnOSM20(−) NP NOAEL could not be established from the current results, but the lowest-observed-adverse-effect level was 125 mg/kg. Furthermore, the NPs were associated with a number of undesirable systemic actions. Thus, their use in humans must be approached with caution.

KW - Negative charge

KW - Oral toxicity study

KW - Rat

KW - ZnO

UR - http://www.scopus.com/inward/record.url?scp=84947435519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947435519&partnerID=8YFLogxK

U2 - 10.2147/IJN.S57926

DO - 10.2147/IJN.S57926

M3 - Article

C2 - 25565828

AN - SCOPUS:84947435519

VL - 9

SP - 79

EP - 92

JO - International Journal of Nanomedicine

JF - International Journal of Nanomedicine

SN - 1176-9114

ER -